Pfizer and BioNTech have formally asked for FDA approval of a third dose of their ... those seen after the two-dose primary schedule," said Pfizer chief executive Albert Bourla.

It’s only February, but my pick for the Worst Biopharma CEO of 2025 has already been decided: Albert Bourla of Pfizer. Pfizer’s decision to hire Patrizia Cavazzoni, a former top drug ...

Hello! Today, we see the CDC’s path forward with vaccines starting to look more complicated, take note of the cold reception Pfizer CEO Albert Bourla got at the White House, and more.

(JTA) — Albert Bourla, the chief executive officer of Pfizer, was named the winner of the 2022 Genesis Prize, the award sometimes called the “Jewish Nobel,” and pledged his winnings to ...

In a year in which he faced down a challenge from an activist investor, Pfizer CEO Albert Bourla, Ph.D., received a 14% total pay increase, according (PDF) to a securities filing.

U.S. drugmaker Pfizer PFE.N is going “all in” to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Executive Officer Albert Bourla said at the ...

Albert Bourla said Pfizer expects to price its treatment, called Paxlovid, close to where rival Merck & Co Inc has priced its oral antiviral drug candidate. The companies said the vaccine ...

Pfizer Chief Executive Albert Bourla says recent Seagen acquisition provides "tremendous opportunity for growth." This interview was recorded on Jan. 15, 2024, at the World Economic Forum meeting ...